Publikation

MRI and CT imaging biomarkers of cerebral amyloid angiopathy in lobar intracerebral hemorrhage.

Wissenschaftlicher Artikel/Review - 07.01.2022

Bereiche
PubMed
DOI
Kontakt

Zitation
Schwarz G, Banerjee G, Hostettler I, Ambler G, Seiffge D, Ozkan H, Browning S, Simister R, Wilson D, Cohen H, Yousry T, Al-Shahi Salman R, Lip G, Brown M, Muir K, Houlden H, Jäger R, Werring D. MRI and CT imaging biomarkers of cerebral amyloid angiopathy in lobar intracerebral hemorrhage. Int J Stroke 2022; 18:85-94.
Art
Wissenschaftlicher Artikel/Review (Englisch)
Zeitschrift
Int J Stroke 2022; 18
Veröffentlichungsdatum
07.01.2022
eISSN (Online)
1747-4949
Seiten
85-94
Kurzbeschreibung/Zielsetzung

Cerebral amyloid angiopathy (CAA), a common cause of intracerebral hemorrhage (ICH), is diagnosed using the Boston criteria including magnetic resonance imaging (MRI) biomarkers (cerebral microbleeds (CMBs) and cortical superficial siderosis (cSS). The simplified Edinburgh criteria include computed tomography (CT) biomarkers (subarachnoid extension (SAE) and finger-like projections (FLPs)). The underlying mechanisms and diagnostic accuracy of CT compared to MRI biomarkers of CAA are unknown.